Royalty Pharma plc Board of Directors

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Mr. Pablo Gerardo Legorreta

Mr. Pablo Gerardo Legorreta

Founder, Chairman of the Board & CEO

Dr. Marshall Jonathan Urist M.D., Ph.D.

Dr. Marshall Jonathan Urist M.D., Ph.D.

Executive Vice President of Research & Investments

Mr. Eric Cornelius Schneider

Mr. Eric Cornelius Schneider

Senior VP & Chief Technology Officer

Mr. Christopher Hite

Mr. Christopher Hite

Vice Chairman & Executive VP

Mr. Ashwin Pai M.D.

Mr. Ashwin Pai M.D.

Executive Vice President of Investments

Mr. George Wingate Lloyd

Mr. George Wingate Lloyd

Executive VP of Investments & Chief Legal Officer

Dr. James Folmar Reddoch Ph.D.

Dr. James Folmar Reddoch Ph.D.

Executive VP of Investments & Chief Scientific Officer

Mr. Arthur Richard McGivern J.D.

Mr. Arthur Richard McGivern J.D.

Executive Vice President of Investments & General Counsel

Ms. Kristin Stafford

Ms. Kristin Stafford

Senior VP & Chief Accounting Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.